Adocia SA (ADOC.PA)
EUR 3.85
(2.67%)
EUR 3.85
(2.67%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.91 EUR | -122.09% |
| 2022 | -0.86 EUR | 76.94% |
| 2021 | -3.73 EUR | -11.68% |
| 2020 | -3.34 EUR | -24.63% |
| 2019 | -2.68 EUR | -368.0% |
| 2018 | 1.00 EUR | 180.0% |
| 2017 | -1.25 EUR | -4.17% |
| 2016 | -1.20 EUR | -163.16% |
| 2015 | 1.90 EUR | 157.06% |
| 2014 | -3.33 EUR | -375.71% |
| 2013 | -0.70 EUR | 30.0% |
| 2012 | -1.00 EUR | 31.03% |
| 2011 | -1.45 EUR | -23.93% |
| 2010 | -1.17 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.62 EUR | 0.0% |
| 2023 Q2 | -1.03 EUR | -101.96% |
| 2023 Q3 | -0.52 EUR | 49.51% |
| 2023 Q4 | -0.88 EUR | -69.23% |
| 2023 Q1 | -0.51 EUR | 60.16% |
| 2023 FY | - EUR | -122.09% |
| 2022 Q1 | 0.26 EUR | 115.2% |
| 2022 Q2 | 0.55 EUR | 111.54% |
| 2022 Q3 | -0.69 EUR | -225.45% |
| 2022 Q4 | -1.28 EUR | -85.51% |
| 2022 FY | - EUR | 76.94% |
| 2021 Q1 | -0.76 EUR | 53.37% |
| 2021 Q3 | -0.86 EUR | 43.05% |
| 2021 Q4 | -1.71 EUR | -98.84% |
| 2021 FY | - EUR | -11.68% |
| 2021 Q2 | -1.51 EUR | -98.68% |
| 2020 FY | - EUR | -24.63% |
| 2020 Q1 | -0.86 EUR | -6.17% |
| 2020 Q2 | -1.71 EUR | -98.84% |
| 2020 Q4 | -1.63 EUR | -98.78% |
| 2020 Q3 | -0.82 EUR | 52.05% |
| 2019 Q2 | -1.87 EUR | -98.94% |
| 2019 FY | - EUR | -368.0% |
| 2019 Q4 | -0.81 EUR | -92.86% |
| 2019 Q3 | -0.42 EUR | 77.54% |
| 2019 Q1 | -0.94 EUR | -327.27% |
| 2018 Q1 | 0.72 EUR | 163.16% |
| 2018 Q4 | -0.22 EUR | 0.0% |
| 2018 FY | - EUR | 180.0% |
| 2018 Q3 | -0.22 EUR | -130.56% |
| 2018 Q2 | 0.72 EUR | 0.0% |
| 2017 FY | - EUR | -4.17% |
| 2017 Q4 | -1.14 EUR | 0.0% |
| 2017 Q3 | -1.14 EUR | -332.65% |
| 2017 Q2 | 0.49 EUR | 0.0% |
| 2017 Q1 | 0.49 EUR | 268.97% |
| 2016 Q2 | -0.31 EUR | 0.0% |
| 2016 Q3 | -0.29 EUR | 6.45% |
| 2016 Q1 | -0.31 EUR | -175.61% |
| 2016 Q4 | -0.29 EUR | 0.0% |
| 2016 FY | - EUR | -163.16% |
| 2015 Q4 | 0.41 EUR | 0.0% |
| 2015 FY | - EUR | 157.06% |
| 2015 Q3 | 0.41 EUR | -16.33% |
| 2015 Q2 | 0.49 EUR | -2.0% |
| 2015 Q1 | 0.50 EUR | 140.98% |
| 2014 Q1 | -0.45 EUR | -2108.93% |
| 2014 Q3 | -1.22 EUR | -171.11% |
| 2014 Q4 | -1.22 EUR | 0.0% |
| 2014 FY | - EUR | -375.71% |
| 2014 Q2 | -0.45 EUR | 0.0% |
| 2013 Q1 | -0.37 EUR | -8.82% |
| 2013 Q2 | -0.37 EUR | 0.0% |
| 2013 Q3 | 0.02 EUR | 106.05% |
| 2013 Q4 | 0.02 EUR | 0.0% |
| 2013 FY | - EUR | 30.0% |
| 2012 FY | - EUR | 31.03% |
| 2012 Q4 | -0.34 EUR | 0.0% |
| 2012 Q3 | -0.34 EUR | 0.0% |
| 2011 FY | - EUR | -23.93% |
| 2010 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -1491.667% |
| ABIVAX Société Anonyme | -3.43 EUR | 44.315% |
| Aelis Farma SA | -0.39 EUR | -389.744% |
| Biophytis S.A. | -12.55 EUR | 84.781% |
| Advicenne S.A. | -0.67 EUR | -185.075% |
| genOway Société anonyme | 0.17 EUR | 1223.529% |
| IntegraGen SA | -0.03 EUR | -7274.517% |
| Medesis Pharma S.A. | -0.80 EUR | -138.75% |
| Neovacs S.A. | -0.00 EUR | -76300.0% |
| NFL Biosciences SA | -0.46 EUR | -315.217% |
| Plant Advanced Technologies SA | 0.07 EUR | 2828.571% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -1998.901% |
| Sensorion SA | -0.17 EUR | -1023.529% |
| Theranexus Société Anonyme | -0.88 EUR | -117.045% |
| TME Pharma N.V. | -1.34 EUR | -42.537% |
| Valbiotis SA | -0.59 EUR | -223.729% |
| TheraVet SA | -0.49 EUR | -289.796% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -1173.333% |
| DBV Technologies S.A. | -0.71 EUR | -169.014% |
| Genfit S.A. | -0.58 EUR | -229.31% |
| GeNeuro SA | -0.59 EUR | -223.729% |
| Innate Pharma S.A. | -0.09 EUR | -1929.756% |
| Inventiva S.A. | -2.43 EUR | 21.399% |
| MaaT Pharma SA | -1.73 EUR | -10.405% |
| MedinCell S.A. | -0.88 EUR | -117.045% |
| Nanobiotix S.A. | -1.08 EUR | -76.852% |
| OSE Immunotherapeutics SA | -1.18 EUR | -61.864% |
| Poxel S.A. | -0.91 EUR | -109.89% |
| GenSight Biologics S.A. | -0.54 EUR | -253.704% |
| Transgene SA | -0.22 EUR | -768.182% |
| Valneva SE | -0.73 EUR | -161.644% |